citarinostat

Ligand id: 9426

Name: citarinostat

Structure and Physico-chemical Properties

2D Structure
Calculated Physico-chemical Properties
Hydrogen bond acceptors 6
Hydrogen bond donors 3
Rotatable bonds 13
Topological polar surface area 107.45
Molecular weight 467.17
XLogP 5.1
No. Lipinski's rules broken 2

Molecular properties generated using the CDK

No information available.
Summary of Clinical Use
ACY-241 is in Phase 1 clinical trial in combination treatments for multiple myeloma, malignant melanoma, non-small cell lung cancer (NSCLC) and other solid tumours. Click here to link to ClinicalTrials.gov's list of ACY-241 trials.